COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 18
SponsorUniversity Hospital, Akershus
About this trial
Prospective cohort study of COVID-19 infection among children in Norway.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
350 Participants
are grouped into 2 trial groupsLocations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Akershus universistetssykehusRecruiting Lørenskog
Norway
NorwaySponsors and collaborators
University Hospital, Akershus
Lead sponsor
St. Olavs Hospital
Collaborator
Helse Stavanger HF
Collaborator
Haukeland University Hospital
Collaborator
University Hospital of North Norway
Collaborator
Alesund Hospital
Collaborator
Norwegian Institute of Public Health
Collaborator
The University of New South Wales
Collaborator
University of Bristol
Collaborator
Sykehuset Ostfold
Collaborator
Nordlandssykehuset HF
Collaborator
Vestre Viken Hospital Trust
Collaborator
Helse Fonna
Collaborator
Helse Nord-Trøndelag HF
Collaborator
Oslo University Hospital
Collaborator
Sykehuset Innlandet HF
Collaborator
Source ClinicalTrials.gov